Please login to the form below

Not currently logged in
Email:
Password:

DH appoints clinical director for informatics

The Department of Health (DH) has appointed Charles Gutteridge as the first national clinical director for informatics

The Department of Health (DH) has appointed Charles Gutteridge as the first national clinical director for informatics. He takes up his appointment during January.

Charles Gutteridge has been the medical director at St Bartholomew's Hospital (Barts) and the London Trust since 2002 and a consultant haematologist both at Barts and at Newham General Hospital.  He is a fellow of the Royal College of Physicians and the Royal College of Pathologists.

As a member of the London review acute group, Gutteridge was involved in providing clinical advice to Lord Darzi's review of health provision in London. He also chaired the Association of UK University Hospitals Medical Directors.
Gutteridge has been strongly involved in patient safety, confidentiality and informatics issues at Barts. He was the Caldicott Guardian for Barts, led the Safer Patients Initiative 2006-8 and chaired the Clinical Informatics Design Authority which gave clinical advice about improving the use of Cerner Millennium at the Trust.

Gutteridge said: "This is an exciting time to be at the cutting edge of delivering informatics to improve patient care. As recent events have shown, there is a sea change in clinical attitudes to informatics and the National Programme for IT. 

"My colleagues know that good, accessible information enormously raises the quality of treatment and diagnosis we can provide to the public. My work with medical under-graduates confirms that these expectations are strong amongst the next generation of doctors. I hope to contribute to encouraging those attitudes and enabling dialogue between clinical staff, patients and informatics providers."

6th January 2010

From: Healthcare

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PharmiWeb Solutions

PharmiWeb Solutions creates, delivers and manages digital solutions for the pharmaceutical and healthcare segment. From digital marketing, to patient education...

Latest intelligence

Theresa Heggie
Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe
Theresa Heggie talks about the biotech’s 16-year path to market, and the promise of its ‘gene silencing’ medicines...
patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...

Infographics